How Will the Urinary Tract Infection Treatment Market Grow? Key Trends and Opportunities for 2025 and Beyond
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
What fueled the previous growth in the urinary tract infection treatment market?
The market size for treating urinary tract infections has witnessed consistent growth in the past few years. The market is expected to expand from a valuation of $10.52 billion in 2024 to approximately $10.78 billion in 2025, displaying a compound annual growth rate (CAGR) of 2.5%. Factors contributing to this expansion during the historic period include the discovery of new antibiotics, the use of urinary catheters, implementation of clinical guidelines and protocols, enhancing patient awareness and education, and ongoing research in women’s health.
What will be the urinary tract infection treatment market size in the future?
The market for treating urinary tract infections is anticipated to progressively expand over the next several years, reaching a valuation of $12.45 billion in 2029, with a compound annual growth rate (CAGR) of 3.7%. This predicted growth in the forecast period is credited to the emergence of non-antibiotic treatments, increased bacterial resistance, bespoke treatment methods, telemedicine services, remote consultations, and public health education initiatives. Microbiome-based therapies, phage therapy, point-of-care testing, nutritional interventions, preventive strategy focus, and community-based interventions are among the considerable trends within this forecast period.
Get your urinary tract infection treatment market report here!
What main drivers are fueling expansion in the urinary tract infection treatment market?
The surge in urinary tract infection cases is anticipated to drive the growth of the urinary tract infection treatment market. Urinary tract infections are bacterial conditions that impact the kidneys, bladder, ureters, urethra, and various other sections of the urinary system. Treatment for these infections plays a crucial role as it proffers multiple ways to counter the infection and encourages healing. In January 2023, the National Institute of Health, a US-based public health research institute, reported that urinary tract infections were the seventh leading cause for patient visits to emergency departments in the US, accounting for over a million visits each year. Out of these, 22% (220,000) are classified as complex UTIs and approximately 100,000 result in hospital admission every year. Consequently, the mounting incidence of urinary tract infections is fueling the expansion of the urinary tract infection treatment market.
What key areas define the segmentation of the global urinary tract infection treatment market?
The urinary tract infection treatment market covered in this report is segmented –
1) By Drug Class: Penicillin And Combinations, Quinolones, Cephalosporin, Aminoglycoside Antibiotics, Sulphonamides, Azoles And Amphotericin B, Tetracycline, Nitrofurantoin
2) By Indication: Complicated UTI, Uncomplicated UTI
3) By Distribution Channel: Hospital Pharmacies, Gynecology And Urology Clinics, Drug Stores, Retail Pharmacies, Online Drug Store
Subsegments:
1) By Penicillin And Combinations: Amoxicillin, Ampicillin, Amoxicillin Or Clavulanate
2) By Quinolones: Ciprofloxacin, Levofloxacin, Norfloxacin
3) By Cephalosporin: Cephalexin, Ceftriaxone, Cefotaxime
4) By Aminoglycoside Antibiotics: Gentamicin, Tobramycin, Amikacin
5) By Sulphonamides: Sulfamethoxazole Or Trimethoprim, Sulfadiazine
6) By Azoles And Amphotericin B: Fluconazole, Itraconazole, Amphotericin B
7) By Tetracycline: Doxycycline, Minocycline
8) By Nitrofurantoin: Nitrofurantoin Monohydrate, Nitrofurantoin Macrocrystals
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=11958&type=smp
Who are the dominant players expanding their reach in the urinary tract infection treatment market?
Major companies operating in the urinary tract infection treatment market include Pfizer Inc., F. Hoffmann-La Roche Ltd, Merck & Co. Inc, AbbVie Inc., Allergan Plc, Bayer AG, Novartis International AG., Sanofi S.A., Bristol-Myers Squibb Company, Thermo Fisher Scientific Inc., AstraZeneca plc, GlaxoSmithKline PLC, Eli Lilly and Company, Boehringer Ingelheim GmbH, Teva Pharmaceutical Industries Ltd, Sun Pharmaceutical Industries Ltd, Dr. Reddy’s Laboratories Ltd., Bio-Rad Laboratories Inc., Cipla Ltd, Hikma Pharmaceuticals PLC, Lupin Limited, Almirall SA, Torrent Pharmaceuticals Limited, Glenmark Pharmaceuticals Limited, Mylan N.V.
How are evolving market trends shaping urinary tract infection treatment Strategies?
A significant trend emerging in the urinary tract infection treatment market is the adoption of cutting-edge diagnostic technologies. To maintain their market position, companies within this sector are actively innovating new products. For example, AccessDx Laboratory, a diagnostic lab based in the US, launched UTI PROx Panel in April 2023. This product is tailored to provide healthcare providers with superior insights that enhance clinical care and support decision-making in the management of suspected, complex, or recurring urinary tract infections.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=11958
Which regions are emerging as leaders in the urinary tract infection treatment market?
North America was the largest region in the urinary tract infection treatment market in 2024. The regions covered in the urinary tract infection treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Similar Reports By The Business Research Company:
Polymerase Chain Reactions (PCR) Devices, Reagents And Uses Global Market Report 2024
Styrene Butadiene Rubber (SBR) Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/styrene-butadiene-rubber-sbr-global-market-report
Polymer Biomaterial Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/polymer-biomaterial-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
